Latest news and research on all cancers and treatments, updated several times a week
That's one of more than 30 cancer types for which the drug, designated a ... They mobilize the body's immune system to ''uncloak'' and attack cancer ...
Emerging data on the role of inflammation and the immune system in the development, growth, and spread of breast tumors have focused increased ...
MedImmune plans to pair Omnis' vesicular stomatitis virus (VSV) with its own “immunotherapeutic” drugs that use the body's immune system to attack ...
Long Island scientists have developed miniature pancreatic "organoids" that for the first time provide investigators with living three-dimensional ...
Concurrent chemoradiotherapy (CCRT) may help increase the two-year survival rate of patients with locally advanced pancreatic cancer (LAPC) or ...
Cancer Council Victoria is seeking 15,000 patients nationally to investigate the causes of less common cancers, including leukaemia, pancreatic ...
The "ALPINE" study (Antibody therapy in first-Line Pancreatic cancer Investigating anti-Notch Efficacy and safety) is assessing tarextumab with ...
Nab-paclitaxel has already recently been approved for the treatment of breast and pancreatic cancer. Its effectiveness against bile duct cancers has ...
"So for example, one of the regions we found is also involved in the risk of pancreatic cancer, another region that's also involved in the risk of breast ...
After Gilead Sciences won FDA approval for its cancer drug Zydelig last ... Imbruvica's potential use in lung, breast, colon, and pancreatic cancer.
A fast and accurate urine test for bladder cancer developed by A*STAR researchers has the potential to replace the currently used invasive physical ...
By offering two tests — UroVysion, the company's FISH-based bladder cancer kit, and an assay based on FGFR3mutations — Abbott is "poised to help ...
Dr Kiltie hopes to understand when patients diagnosed with muscle invasive bladder cancer are more likely to respond to radiotherapy or should be ...
These studies are testing the drug's effectiveness against bladder cancer, colorectal cancer, renal cancer and non-small cell lung cancer. The COMP ...
Two drug companies have agreed to pay M.D. Anderson Cancer Center $100 million in stock for the right to patent an experimental cancer treatment ...
This report focuses on the rising potential for the newest and most promising of cancer treatments: cancer immunotherapy. Cancer immunotherapy ...
In 2015, Juno Therapeutics will explore use of its revolutionary immunotherapycancer treatments on solid tumors, figure out how to make its cell ...
... U.S. to offer the novel immunotherapy for advanced prostate cancer since receiving marketing authorization in the European Union (EU) in 2013.
Cancer News in Science Daily
Cancer fighting chimeric antigen receptor (CAR) T cells, developed in the Sentman laboratory of Dartmouth’s Norris Cotton Cancer Center, are taking the next step into a Phase I clinical trial beginning early in 2015.
The annual rate of primary tumor removal for advanced stage IV colorectal cancer has decreased since 1988 and the trend toward nonsurgical management of the disease noted in 2001 coincides with the availability of newer chemotherapy and biologic treatments, according to a report.
While considered a delicacy in some parts of the world, snails have found a more intriguing use to scientists and the medical profession offering a plethora of research possibilities. Cone snails are marine mollusks, just as conch, octopi and squid, but they capture their prey using venom. The venom of these marine critters provides leads for detection and possible treatment of some cancers and addictions.
Nanoparticle drugs -- tiny containers packed with medicine and with the potential to be shipped straight to tumors -- were thought to be a possible silver bullet against cancer. However new cancer drugs based on nanoparticles have not improved overall survival rates for cancer patients very much. Scientists now think that failure may have less to do with the drugs and tumors than it does the tumor's immediate surroundings.
Tambahkan Komentar